The Senate sidelined a war powers resolution Wednesday that would have put a check on President Donald Trump’s ability to carry out further military attacks on Venezuela, as the president put intense ...
This productive discussion with FDA reviewers gives Ernest leadership renewed confidence our development plan is on the ...
FDA feedback supports 505(b)(2) filing in H2 2026; No additional studies required beyond current planned 32-subject clinical trial ESTERO, FL / ACCESS Newswire / January 7, 2026 / Aspire Biopharma ...
Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial ...
The FDA endorsed a ≥2-point reduction on a visual analogue scale for pain as a clinically meaningful endpoint for urcosimod in NCP. NCP is a chronic ocular pain syndrome with no FDA-approved therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results